According to the BMI healthcare report, Canada’s pharmaceutical sales are forecasted to leap to US$22.730bn by the year 2020. This is up from 2015’s US$19.6bn.1 Canada has been ranked in the top 10 of cold chain export markets in a recent industry report.2 Challenges such as country pecific regulations, non-tariff barriers and clearing customs stand as hurdles for both cold chains transporting pharma products both pre and post market approval. With biologics filling a vast amount R&D pipelines successful temperature control during transit is at the forefront of many strategies.
With the strength of this region in mind, Pharma Logistics IQ surveyed its network to pinpoint trends within Canada’s clinical and commercial temperature controlled supply chains.
Download the infographic below.
| Have Your Say Rate this feature and give us your feedback in the comments section below |